Brian Nowosielski

Amina Abubakar, PharmD, AAHIVP, joined Drug Topics to discuss her career journey as an independent pharmacy owner and the ways in which she’s been able to grow her business.

Researchers investigated Norwegian pharmacists to understand their expertise, and potential knowledge gaps, regarding issues of epilepsy and treatment using antiseizure medication.

At the Total Pharmacy Solutions Summit Spring 2025 event, diagnostics experts Jenna Anderson and Amanda Wiley explored community pharmacists’ role in at-home testing.

Researchers developed, pilot-tested, and evaluated the feasibility of a telehealth electronic application that simulated pharmacists’ prescribing of contraceptives to adolescents and young adults.

Researchers conducted a systematic review to summarize research that has addressed social media’s impact on skin health promotion activities.

At the Total Pharmacy Solutions Summit Spring 2025, Ashley Keller, CPhT, discussed innovative ways to make pharmacy businesses thrive and, in turn, benefit patients.

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

Pharmacists have shown the ability to stand out among other providers amid some of the most debilitating natural disasters in recent history.

Using the “Psoriasis and Beyond” survey design, researchers addressed patients’ awareness of psoriatic diseases and their associated comorbidities.

A Patient Care Journey from a Pharmacist Perspective

Researchers aimed to understand the treatment goals and preferences of young patients with atopic dermatitis and their caregivers.

The event will focus on revenue stream diversification, providing independent pharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.

Joey Mattingly, PharmD, MBA, PhD, and Marta Wosinska, PhD, discussed what pharmacy businesses can do to prepare for the potential implementation of tariffs on pharmaceutical products.

Drug Topics was joined by Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, to discuss the potential impact tariffs may have if they are widely implemented within the pharmaceutical industry.

In the suit, the companies claim the law puts an unconstitutional restriction on interstate commerce.

Health care economist Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed the potential impact pharmaceutical tariffs may have on access to generic and brand-name drugs.

Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed her ongoing research regarding the potential impact of pharmaceutical tariffs on the prescription drug market.

In a world where drug shortages are one of the most pressing issues for pharmacy businesses, there are certain tools making a significant difference in helping patients access their drugs at the pharmacy.

Currently under development, the manufacturer’s investigational pandemic influenza vaccine is designed to target the H5 avian influenza virus, or bird flu.

Alecia Lashier, chief automation officer and executive vice president at iA, discusses transformations in the pharmacy industry and how they’ve impacted pharmacists and their businesses.

Researchers evaluated PBM reimbursement practices in Medicare and whether they resulted in out-of-pocket cost increases for Part D beneficiaries.

Researchers conducted a scoping review to evaluate conversational AI agents and their use in pharmacy education.

Researchers aimed to estimate the impact of using behavioral science principles within communication intended for hypertension medication adherence.

Researchers explored how relationships between physicians, pharmacists, and patients are associated with the use of generic drugs in Japanese pharmacies.

David Swenson, RPh, discussed drug shortage technology that his company is helping bring to community pharmacies across the country.

PBM expert Antonio Ciaccia, president of 3 Axis Advisors and CEO of 46brooklyn Research, discussed recent events in the pharmacy benefits industry and how it is moving toward PBM reform.

Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discussed his role in uncovering PBM practices and pharmacy consulting.

Researchers explored the current evidence regarding women’s reactions to biological therapies for treating atopic dermatitis during pregnancy.

David Swenson, RPh, Founder and CEO of ShortStop Rx, joined Drug Topics to discuss the CCT Rx Shortage Solutions technology and how it’s helping combat drug shortages in the US.